摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-fluoro-3,5-dimethoxyphenyl)-8-[(3-hydroxypiperidin-1-yl)carbonyl]-1-methyl-1,3,4,7-tetrahydro-2H-pyrrolo[3’,2’:5,6]pyrido[4,3-d]pyrimidin-2-one | 1513856-82-0

中文名称
——
中文别名
——
英文名称
3-(2-fluoro-3,5-dimethoxyphenyl)-8-[(3-hydroxypiperidin-1-yl)carbonyl]-1-methyl-1,3,4,7-tetrahydro-2H-pyrrolo[3’,2’:5,6]pyrido[4,3-d]pyrimidin-2-one
英文别名
US10131667, Example 31;11-(2-fluoro-3,5-dimethoxyphenyl)-4-(3-hydroxypiperidine-1-carbonyl)-13-methyl-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-12-one
3-(2-fluoro-3,5-dimethoxyphenyl)-8-[(3-hydroxypiperidin-1-yl)carbonyl]-1-methyl-1,3,4,7-tetrahydro-2H-pyrrolo[3’,2’:5,6]pyrido[4,3-d]pyrimidin-2-one化学式
CAS
1513856-82-0
化学式
C24H26FN5O5
mdl
——
分子量
483.499
InChiKey
YVNRREHUQLAIJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    35
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    111
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
    申请人:Incyte Corporation
    公开号:US20170137424A1
    公开(公告)日:2017-05-18
    The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
    本发明涉及三环化合物以及其药物组成物,它们是一种或多种FGFR酶的抑制剂,可用于治疗与FGFR相关的疾病,如癌症。
  • Substituted tricyclic compounds as FGFR inhibitors
    申请人:Incyte Corporation
    公开号:US11053246B2
    公开(公告)日:2021-07-06
    The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
    本发明涉及三环化合物及其药物组合物,它们是一种或多种表皮生长因子受体酶的抑制剂,可用于治疗表皮生长因子受体相关疾病,如癌症。
  • US9611267B2
    申请人:——
    公开号:US9611267B2
    公开(公告)日:2017-04-04
  • [EN] SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS<br/>[FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS UTILISÉS COMME INHIBITEURS DE FGFR
    申请人:INCYTE CORP
    公开号:WO2014007951A2
    公开(公告)日:2014-01-09
    The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
查看更多